Vimal Elaichi Ad Controversy: Maharashtra FDA Targets Bollywood Stars for Surrogate Marketing

The Maharashtra Food and Drug Administration (FDA) has escalated its crackdown on surrogate advertising, targeting Bollywood figures Shah Rukh Khan, Ajay Devgn, and Tiger Shroff. The regulator alleges that their promotion of Vimal Elaichi is a legal facade used to market Vimal Pan Masala, a product prohibited within the state. This case is significant because it shifts the legal focus from the manufacturer to the celebrity endorser.

The Legal Basis for Celebrity Liability

At the heart of this dispute is the interpretation of the Food Safety Act. While celebrities often argue they are merely hired talent promoting a legal product—in this case, cardamom (elaichi)—the FDA maintains that the law mandates a higher standard of care. Commissioner Tukaram Mundhe has asserted that the act imposes a specific duty on those who front an ad to ensure the product they are endorsing is not a proxy for something illegal [1].

This approach challenges the traditional "safe harbor" for actors, who previously claimed they were not responsible for the manufacturer's broader brand strategy. By treating the stars as "advertisers" rather than just "faces," the FDA is attempting to establish a precedent where due diligence is a legal requirement for any high-profile endorsement.

Timeline of Regulatory Action

The proceedings began in mid-2026, moving from administrative notices to potential prosecution:

• August 11, 2026: The Maharashtra FDA issued show-cause notices to the three actors, providing a 15-day window for a response [1].
• September 14, 2026: The Delhi High Court refused to intervene in the matter, dismissing a petition by PB Agro LLP (the master licensee) on the grounds that the court lacked territorial jurisdiction since the notices originated in Mumbai [1].
• September 18, 2026: Commissioner Mundhe confirmed that while two actors replied, one failed to do so, leading the FDA to initiate prosecution and adjudication proceedings against that individual [1].

Comparing Celebrity Stances

The actors involved have taken varying paths when facing public and legal scrutiny over these campaigns. Ajay Devgn has previously maintained that his personal choice was to promote elaichi specifically. Shah Rukh Khan has historically argued that if a product is legally sold, he is simply performing a professional job to earn revenue. In contrast, Akshay Kumar, who was part of the earlier 2022 campaign, chose to apologize and donate his fees to charity after facing backlash, a move that highlights the volatility of celebrity brand associations in the current regulatory climate.